WO2026009133 - ANTI-B7-H3 ANTIBODY
National phase entry is expected:
Publication Number
WO/2026/009133
Publication Date
08.01.2026
International Application No.
PCT/IB2025/056636
International Filing Date
30.06.2025
Title **
[English]
ANTI-B7-H3 ANTIBODY
[French]
ANTICORPS ANTI-B7-H3
Applicants **
DAIICHI SANKYO COMPANY, LIMITED
Inventors
SHIBUTANI, Tomoko
KAWAMURA, Junko
Priority Data
63/666,451
01.07.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2377 | |
| EPO | Filing, Examination, Granting | 12327 | |
| Japan | Filing, Examination, Granting | 2400 | |
| South Korea | Filing, Examination, Granting | 2473 | |
| USA | Filing, Examination, Granting | 8140 |
Total:
27,717
Contact Us
Abstract[English]
ANTI-B7-H3 ANTIBODY In some aspects, an anti-B7-H3 antibody or its use is provided.[French]
Selon certains aspects, l'invention concerne un anticorps anti-B7-H3 ou son utilisation.